Three oncology perspectives have analyzed a cancer case: Tumor Board: Guidelines: The diagnosis of poorly...

Question asked:

Three oncology perspectives have analyzed a cancer case: Tumor Board: Guidelines: The diagnosis of poorly differentiated squamous cell carcinoma of the anus is pathologically confirmed and correct, but the clinical picture suggests persistent/recurrent disease rather than complete response to Nigro protocol chemoradiation. The diagnosis is incomplete without definitive staging - we have conflicting data showing initial T3N1 disease, post-treatment imaging suggesting response (0.9 cm primary), yet October 2025 PET/CT demonstrates intensely hypermetabolic anorectal lesion LARGER than baseline with persistent FDG-avid left inguinal node. Recommendation: Immediate multidisciplinary tumor board review required. Complete restaging per NCCN guidelines: (1) MRI pelvis with contrast to define local extent and differentiate tumor from post-radiation changes/abscess, (2) Biopsy of persistent left inguinal node for pathologic confirmation of nodal disease, (3) Chest CT to rule out distant metastases. The patient likely has persistent/recurrent cT3-4N1 disease and requires discussion of salvage options including abdominoperineal resection (APR) with inguinal node dissection versus clinical trial enrollment given poor differentiation and potential treatment resistance. Tumor Board: Cutting Edge: The diagnosis of poorly differentiated squamous cell carcinoma of the anus is histologically confirmed and correct, but critically incomplete from a precision oncology standpoint. The presence of ATM and BRCA mutations in anal SCC—a highly unusual finding that warrants comprehensive genomic profiling—suggests potential DNA damage repair deficiencies that could dramatically alter treatment strategy, particularly given the apparent treatment resistance (persistent FDG-avid disease post-Nigro protocol with SUV increase on 10/29 PET). Recommendation: URGENT: Order comprehensive genomic profiling (Foundation CDx or Tempus xT) with RNA-seq to characterize ATM/BRCA mutations (germline vs somatic), assess TMB/MSI/HRD score, and identify actionable targets. Simultaneously: (1) Confirm germline vs somatic status via blood germline testing (Invitae/Myriad), (2) Obtain HPV genotyping and PD-L1 IHC on existing biopsy tissue, (3) Consider FNA of left inguinal node for definitive staging, (4) Enroll in institutional tumor board to discuss clinical trial eligibility—potential matches include PARP inhibitor combinations (NCT03682289: olaparib+durvalumab in DDR-deficient tumors), anti-PD-1 therapy if MSI-H/TMB-high, or APR salvage surgery if localized recurrence confirmed. The ATM/BRCA mutations represent a precision medicine opportunity being missed. Tumor Board: Whole Person: The diagnosis of poorly differentiated squamous cell carcinoma of the anus appears correct based on pathology confirmation, but the clinical picture is complicated by post-radiation changes making it difficult to distinguish treatment effect from persistent/recurrent disease. The supportive care team is most concerned about the severe pain, bleeding, perianal abscess, and anemia that are significantly impacting quality of life and treatment tolerance. Recommendation: From a supportive care perspective: (1) Aggressive pain management is essential - consider topical lidocaine, sitz baths, stool softeners, and potentially opioid rotation if current regimen inadequate; (2) Nutritional support is critical given bleeding, anemia, and painful defecation - consider high-protein, low-residue diet, iron supplementation if tolerated, and possibly temporary feeding tube if oral intake becomes inadequate; (3) The perianal abscess requires definitive treatment (drainage/antibiotics) before any further cancer therapy; (4) Repeat biopsy of the PET-avid areas is needed to confirm active cancer vs. radiation effect - this will guide whether additional local therapy, systemic therapy, or supportive care is most appropriate. The oncology team should clarify staging (complete vs. incomplete response) and discuss treatment goals given the challenging anatomy and quality of life impact. Synthesize these perspectives. Respond in this exact JSON format: { "synthesis": "A 2-3 sentence synthesis of the key takeaways for the patient", "consensus": ["Point where all three agree", "Another point of agreement"], "divergence": ["Point where they disagree", "Another area of disagreement"] } Focus on actionable insights for the patient's next doctor conversation.